Liverpool School of Tropical Medicine
Department of Clinical Sciences
Katerina graduated with a BSc (Hons) in Biological and Medical Sciences in 2016 from the University of Liverpool. After graduating, she worked for a short period as a Journal Development Editor, managing a portfolio of open access journals at BioMed Central. Following this, she was awarded a training scholarship from Unilever to undertake a 6 month placement as a visiting research assistant in the Watt Lab at the Centre for Stem Cells and Regenerative Medicine, Kings College London. In 2018, Katerina began the MRC Doctoral Training Programme at LSTM, with an integrated MRes at Lancaster University in Global Health: Quantitative and Translational Skills. Katerina is now undertaking her PhD with the Respiratory Clinical Research Group under the supervision of Professor Daniela Ferreira identifying novel pneumococcal pnuemonia protein vaccine candidates. During the COVID-19 pandemic (2020), Katerina undertook a secondment to support a number of SARS-CoV-2 clinical trials, including the ChAdOx1 Vaccine Trial.

Presenter of 1 Presentation

O040 - IDENTIFYING SEROTYPE-INDEPENDENT CORRELATES OF PROTECTION AGAINST PNEUMOCOCCAL COLONISATION IN A HUMAN CHALLENGE MODEL (ID 231)

Session Type
Parallel Session
Date
Tue, 21.06.2022
Session Time
14:50 - 16:20
Room
Grand Ballroom West
Lecture Time
15:35 - 15:45

Abstract

Background

Identification of serotype-independent correlates of protection against S. pneumoniae (Spn) infection will accelerate development of vaccines with broad coverage. In mice, nasopharyngeal-resident memory IL-17A-secreting CD4+ T-cells mediate pneumococcal clearance and systemic IL-17A responses predict resistance to colonisation. We evaluated whether humoral and cellular responses to conserved pneumococcal proteins predict resistance to experimental colonisation.

Methods

A multiplex Luminex assay was used to measure serum IgG to 75 conserved pneumococcal antigens pre- and post-intranasal inoculation with Spn6B in 39 healthy adults. Baseline PBMCs from 60 volunteers were stimulated with killed pneumococcus or 70 antigens. Secreted concentrations of 4 cytokines/chemokines were correlated with subsequent pneumococcal carriage acquisition or density. PBMCs taken pre- and post-challenge were used to evaluate B-cell responses to five selected proteins by ELISpot.

Results

Baseline IgG or B-cell responses did not correlate with protection against colonisation. Successful colonisation associated with significantly increased antibody levels to five antigens and B-cell responses to two antigens increased 29 days post-challenge, whereas there were no significant increases in IgG or B-cell responses in non-colonised volunteers. PBMC-elicited protein-specific IL-17A responses were detected at baseline but did not correlate with carriage acquisition or density. Protein-specific MCP-1 levels at baseline were higher in non-colonised volunteers.

Conclusions

Baseline IgG, B-cell or PBMC-elicited IL-17A responses to single protein antigens did not predict resistance to experimental colonisation in this study. The association between MCP-1, a key chemokine for monocyte recruitment, and colonisation may suggest a possible correlate of protection. Further work is needed to assess whether protein-specific immune responses post-colonisation protect against re-colonisation.

Hide